Cargando…

Factors influencing decision making and antibiotic prescribing patterns for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) among non-infectious physicians in Thailand: a qualitative study

The treatment of carbapenem-resistant Enterobacteriaceae (CRE) is diverse in each region due to the difference in local resistant patterns of CRE. We aimed to explore how physicians in Thailand decide on selection options for treating CRE infections. In this study, 25 physicians who were not infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soontaros, Suluck, Leelakanok, Nattawut, Mepradis, Yuttaphum, Auamnoy, Titinun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Clinical Pharmacology and Therapeutics 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810490/ https://www.ncbi.nlm.nih.gov/pubmed/36632079 http://dx.doi.org/10.12793/tcp.2022.30.e18

Ejemplares similares

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
por: Suay-García, Beatriz, et al.
Publicado: (2019)

Cost-effectiveness of carbapenem-resistant Enterobacteriaceae (CRE) surveillance in Maryland
por: Lin, Gary, et al.
Publicado: (2022)

CaseFinder: A Flexible Real-time Online Surveillance Registry for Infectious Disease Physicians to Report Cases of Carbapenem-resistant Enterobacteriaceae (CRE)
por: Curtis, Donald, et al.
Publicado: (2013)

359 Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) at an Academic Medical Center
por: Leiner, Charles, et al.
Publicado: (2014)

1249. Emergence of Diverse Carbapenem-Resistant Enterobacteriaceae (CRE) in the Dominican Republic
por: Fermin, Rita Rojas, et al.
Publicado: (2018)

Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
por: Zhang, Rong, et al.
Publicado: (2017)

499. Carbapenem-resistant Enterobacteriaceae (CRE)-associated Infections and Prolonged Colonization among Hospitalized Patients Colonized by CRE
por: Khawcharoenporn, Thana, et al.
Publicado: (2019)

533. Impact of Different Definitions on Reported Rates of Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Passaretti, Catherine, et al.
Publicado: (2019)

509. The Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) in a Community Hospital Setting
por: Lewis, Sally, et al.
Publicado: (2019)

Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from Blood by Heparin-Functional Hemoperfusion Media
por: McCrea, Keith, et al.
Publicado: (2014)

Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice
por: Zhang, Zhijie, et al.
Publicado: (2022)

Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection
por: Lin, Qun, et al.
Publicado: (2021)

Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome
por: Madney, Youssef, et al.
Publicado: (2023)

Endogenous Bacteremia Caused by Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae (CRE) in Immunocompromised Children
por: Almasian Tehrani, Nasim, et al.
Publicado: (2023)

355 Carbapenem-Resistant Enterobacteriaceae (CRE) Distribution within the Veterans Affairs Healthcare System: 2013
por: Ryono, Russell, et al.
Publicado: (2014)

843. Increased Carbapenemase Testing Following Implementation of VA Guidelines for Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Fitzpatrick, Margaret A, et al.
Publicado: (2020)

1432. Population-based Surveillance of Carbapenem-Resistant Enterobacteriaceae (CRE) in Alameda County, 2017-2020
por: Horwich-Scholefield, Sam, et al.
Publicado: (2020)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

532. Can Saccharomyces boulardii Therapy Be Effective in Decolonizing Rectal Carbapenem-Resistant Enterobacteriaceae (CRE) Colonization?
por: Resat Sipahi, Oguz, et al.
Publicado: (2019)

2130. Detection of Carbapenemase-Producing Organisms and Impact on Antimicrobial Utilization for Carbapenem-Resistant Enterobacteriaceae (CRE) Infections
por: Minor, Sarah Brooks, et al.
Publicado: (2019)

2276. Clinical Epidemiology of the Carbapenem-Resistant Enterobacteriaceae (CRE) Epidemic in Colombia: A Multicenter Prospective Study
por: Valderrama-Beltrán, Sandra Liliana, et al.
Publicado: (2019)

537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Campbell, Eileen, et al.
Publicado: (2019)

1591. Antibiotic Utilization Trends in Veterans Affairs (VA) Patients with Carbapenem Resistant Enterobacteriaceae (CRE) Infections
por: Traversa, Alfredo, et al.
Publicado: (2020)

Treatment of Ventriculitis and Meningitis After Neurosurgery Caused by Carbapenem-Resistant Enterobacteriaceae (CRE): A Challenging Topic
por: Li, Cuiling, et al.
Publicado: (2023)

1178. A Multicenter Prospective Study of Clinical and Molecular Epidemiological Analysis of Carbapenem-Resistant Enterobacteriaceae (CRE) and Carbapenemase-Producing Enterobacteriaceae (CPE) in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2018)

A multidisciplinary approach to verify and de-label of drug allergic histories in a university hospital in Thailand: a retrospective descriptive study
por: Palapinyo, Sirinoot, et al.
Publicado: (2023)

1726 What Defines Carbapenem-Resistant Enterobacteriaceae (CRE) in a Low Prevalence State? Oregon, 2010 — 2013
por: Maureen Cassidy, P., et al.
Publicado: (2014)

2167. Predicting Carbapenem-Resistant Enterobacteriaceae (CRE) Carriage on Admission using Updated Statewide Hospital Discharge Data
por: Ray, Michael J, et al.
Publicado: (2018)

1251. Contaminated Sinks May be an Environmental Source for Serial Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE) to ICU Patients
por: Lewis, Sarah S, et al.
Publicado: (2018)

Genetic Diversity of Carbapenem-Resistant Enterobacteriaceae (CRE) Clinical Isolates From a Tertiary Hospital in Eastern China
por: Miao, Minhui, et al.
Publicado: (2019)

2247. Real-world Experience with Meropenem–Vaborbactam (M/V) for Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections
por: Shields, Ryan K, et al.
Publicado: (2019)

710. In Vitro Activity and Performance of Available Susceptibility Testing Methods for Eravacycline Against Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Jones, Chelsea E, et al.
Publicado: (2019)

Bacteremia due to Carbapenem-Resistant Enterobacteriaceae (CRE) in New York and New Jersey: A Clinical and Molecular Epidemiologic Analysis
por: Satlin, Michael, et al.
Publicado: (2015)

2450. Antibiotic Treatment for Carbapenem-Resistant Enterobacteriaceae (CRE) and Outcomes in Veterans With Spinal Cord Injury/Disorder (SCI/D)
por: Little, Erica K, et al.
Publicado: (2018)

Environmental Prevalence of Carbapenem Resistance Enterobacteriaceae (CRE) in a Tropical Ecosystem in India: Human Health Perspectives and Future Directives
por: Sivalingam, Periyasamy, et al.
Publicado: (2019)

2134. Differential Changes in Breath Volatile Metabolites to Identify Carbapenem-Resistant Enterobacteriaceae (CRE) in a Murine Pneumonia Model
por: Ismail, Nour, et al.
Publicado: (2019)

525. Evaluation of Implementation of Guidelines for Carbapenem-resistant Enterobacteriaceae (CRE) Prevention Using the Consolidated Framework for Implementation Research (CFIR)
por: Goedken, Cassie, et al.
Publicado: (2019)

Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK
por: Vlachaki, Ioanna, et al.
Publicado: (2021)

Active Surveillance for Carbapenem-Resistant Enterobacterales (CRE) Colonization and Clinical Course of CRE Colonization among Hospitalized Patients at a University Hospital in Thailand
por: Wangchinda, Walaiporn, et al.
Publicado: (2022)

Carbapenem-resistant Enterobacteriaceae (CRE) or Delayed Appropriate Therapy (DAT)—Does One Affect Outcomes More Than the Other Among Patients With Serious Infections Due to Enterobacteriaceae?
por: Lodise, Thomas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f0f6m4883br9j6roa8urqb97il